Astellas Pharma Pink Sheet Forecast - Naive Prediction

ALPMF Stock  USD 9.68  0.07  0.72%   
The Naive Prediction forecasted value of Astellas Pharma on the next trading day is expected to be 9.53 with a mean absolute deviation of 0.27 and the sum of the absolute errors of 16.19. Astellas Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Astellas Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A naive forecasting model for Astellas Pharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Astellas Pharma value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Astellas Pharma Naive Prediction Price Forecast For the 26th of November

Given 90 days horizon, the Naive Prediction forecasted value of Astellas Pharma on the next trading day is expected to be 9.53 with a mean absolute deviation of 0.27, mean absolute percentage error of 0.10, and the sum of the absolute errors of 16.19.
Please note that although there have been many attempts to predict Astellas Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Astellas Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Astellas Pharma Pink Sheet Forecast Pattern

Backtest Astellas PharmaAstellas Pharma Price PredictionBuy or Sell Advice 

Astellas Pharma Forecasted Value

In the context of forecasting Astellas Pharma's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Astellas Pharma's downside and upside margins for the forecasting period are 6.61 and 12.45, respectively. We have considered Astellas Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
9.68
9.53
Expected Value
12.45
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Astellas Pharma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Astellas Pharma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.8299
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2653
MAPEMean absolute percentage error0.0235
SAESum of the absolute errors16.1852
This model is not at all useful as a medium-long range forecasting tool of Astellas Pharma. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Astellas Pharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Astellas Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Astellas Pharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
6.769.6812.60
Details
Intrinsic
Valuation
LowRealHigh
5.748.6611.58
Details
Bollinger
Band Projection (param)
LowMiddleHigh
9.0010.4111.81
Details

Other Forecasting Options for Astellas Pharma

For every potential investor in Astellas, whether a beginner or expert, Astellas Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Astellas Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Astellas. Basic forecasting techniques help filter out the noise by identifying Astellas Pharma's price trends.

Astellas Pharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Astellas Pharma pink sheet to make a market-neutral strategy. Peer analysis of Astellas Pharma could also be used in its relative valuation, which is a method of valuing Astellas Pharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Astellas Pharma Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Astellas Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Astellas Pharma's current price.

Astellas Pharma Market Strength Events

Market strength indicators help investors to evaluate how Astellas Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Astellas Pharma shares will generate the highest return on investment. By undertsting and applying Astellas Pharma pink sheet market strength indicators, traders can identify Astellas Pharma entry and exit signals to maximize returns.

Astellas Pharma Risk Indicators

The analysis of Astellas Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Astellas Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astellas pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Other Information on Investing in Astellas Pink Sheet

Astellas Pharma financial ratios help investors to determine whether Astellas Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Astellas with respect to the benefits of owning Astellas Pharma security.